Page last updated: 2024-08-23

quinapril and Atherogenesis

quinapril has been researched along with Atherogenesis in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bierhaus, A; Cooper, ME; Jandeleit-Dahm, KA; Li, J; Samijono, D; Thomas, MC; Watson, AM1
Allen, TJ; Cooper, ME; de Gasparo, M; Feng, B; Jandeleit-Dahm, KA; Li, J; Schumacher, C; Thomas, MC; Watson, AM1
Allen, TJ; Brasacchio, D; Calkin, AC; Cooper, ME; Jandeleit-Dahm, KJ; Koitka, A; Li, J; Rajan, SN; Sheehy, K; Soro-Paavonen, A; Thomas, MC; Watson, AM1
Allen, TJ; Burrell, LM; Candido, R; Cooper, ME; Davis, BJ; Jandeleit-Dahm, K; Johnston, CI; Lassila, M1

Other Studies

4 other study(ies) available for quinapril and Atherogenesis

ArticleYear
Quinapril treatment abolishes diabetes-associated atherosclerosis in RAGE/apolipoprotein E double knockout mice.
    Atherosclerosis, 2014, Volume: 235, Issue:2

    Topics: Animals; Aorta; Apolipoproteins E; Atherosclerosis; Diabetes Mellitus, Experimental; Male; Mice, Knockout; Plaque, Atherosclerotic; Quinapril; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Renin-Angiotensin System; Tetrahydroisoquinolines

2014
The endothelin receptor antagonist avosentan ameliorates nephropathy and atherosclerosis in diabetic apolipoprotein E knockout mice.
    Diabetologia, 2010, Volume: 53, Issue:1

    Topics: Animals; Antihypertensive Agents; Apolipoproteins E; Atherosclerosis; Blood Pressure; Diabetic Angiopathies; Diabetic Nephropathies; Disease Models, Animal; Endothelin Receptor Antagonists; Hyperglycemia; Hyperlipidemias; Kidney; Kidney Function Tests; Mice; Mice, Knockout; Pyridines; Pyrimidines; Quinapril; Tetrahydroisoquinolines

2010
Delayed intervention with AGE inhibitors attenuates the progression of diabetes-accelerated atherosclerosis in diabetic apolipoprotein E knockout mice.
    Diabetologia, 2011, Volume: 54, Issue:3

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Apolipoproteins E; Atherosclerosis; Diabetes Mellitus, Experimental; Immunohistochemistry; Male; Mice; Mice, Knockout; Peptidyl-Dipeptidase A; Quinapril; Reverse Transcriptase Polymerase Chain Reaction; Tetrahydroisoquinolines

2011
Anti-atherosclerotic and renoprotective effects of combined angiotensin-converting enzyme and neutral endopeptidase inhibition in diabetic apolipoprotein E-knockout mice.
    Journal of hypertension, 2005, Volume: 23, Issue:11

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aorta; Apolipoproteins E; Atherosclerosis; Biomarkers; Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus; Glycated Hemoglobin; Kidney; Kidney Diseases; Male; Mice; Mice, Knockout; Neprilysin; Organ Size; Peptidyl-Dipeptidase A; Protease Inhibitors; Pyridines; Quinapril; Tetrahydroisoquinolines; Thiazepines

2005